Two Israeli IVF labs have RFID. Sixteen still match embryos on paper — and the embryos got swapped.
In November 2024 Israel's State Comptroller (the country's audit regulator) reviewed 18 of the 25 in-vitro fertilisation units (the labs that fertilise eggs outside the body and transfer an embryo back to the womb). Only two had installed electronic-witnessing — the automatic check that tags every dish and tube with a radio chip and blocks a sample mismatch at every step. Fourteen still relied on one lab scientist doing the work and a second checking by eye. Two years earlier a wrong-embryo transfer at Assuta Rishon LeZion produced a child the parents did not share DNA with. The Ministry of Health has put ₪75 million (~€19 million) on the table over three years and is writing mandatory unit-licensing standards for 2025-2026.
01The pain
In September 2022 the in-vitro fertilisation (IVF) lab at Assuta Rishon LeZion, a private hospital in central Israel, implanted the wrong embryo. A girl was born to parents she shared no DNA with. IVF is the lab procedure that fertilises eggs outside the body and transfers an embryo back to the womb. In 2023 a Family Court ordered the child's transfer to her genetic parents.1
In November 2024 Israel's State Comptroller, the country's audit regulator, audited 18 IVF units. Only two had electronic witnessing. The system tags every dish and tube with RFID (Radio Frequency Identification: small chips a reader picks up without scanning by hand), then blocks the wrong sample at every step. Two more units were in procurement. Fourteen still ran on manual double-witnessing: one embryologist (the lab scientist who handles eggs and embryos) doing the work, a second checking by eye. Reported "exception events" jumped to seventeen in the eighteen months after Assuta, against four in the prior six years.2
Units told auditors that cost and infrastructure stopped them buying. Israel is also 111 embryologists short, a 45% gap with a 2-to-3-year training pipeline.3 The Ministry of Health has put ₪75 million (~€19 million) on the table over three years for public-sector units and is writing mandatory licensing standards for 2025-2026.4 Every Israeli IVF unit knows the buy is coming.
Further reading
- 1 Times of Israel — Family Court ruling that the child born in the Assuta Rishon LeZion IVF mix-up must be transferred to her genetic parents (English): timesofisrael.com
- 2 State Comptroller of Israel (Matanyahu Englman), Annual Report, November 2024 — Hebrew summary chapter "In-Vitro Fertilisation in Israel — Regulatory and Oversight Aspects"; documents that only 2 of 18 audited units use electronic-witnessing, cites cost and infrastructure as the deployment barrier, recommends mandatory unit-licensing standards including identification technology: mevaker.gov.il (PDF)
- 3 Doctors.co.il (Israeli physicians' professional community site) — Hebrew article summarising the State Comptroller findings on IVF safety, including the embryologist shortfall and the cost-and-infrastructure barrier to electronic-witnessing deployment: doctors.co.il
- 4 Ynet Health — Hebrew coverage of the Ministry of Health response to the Assuta findings, including the corporate statement that Assuta has deployed new identification technologies and improved risk-management processes, and Dr. Hagar Mizrahi (head of the MoH medicine division) confirming the unit-licensing standard work: ynet.co.il
02Who solves this today
Three self-marketing vendors cataloged below. We read each one's product or distributor page in Hebrew and English; each one concretely addresses IVF sample-mismatch and the electronic-witnessing mechanism the State Comptroller report cites. Two are the global system vendors (CooperSurgical RI Witness and IMT Matcher); one is the Israeli medical-device distributor that imports and supplies the kit locally. Inclusion is not endorsement; it is a record of who currently markets a product page that matches this pain.
Inclusion here is not endorsement. We list companies that publicly market themselves as solving this pain on a product or distributor page we have read. We do not vouch for results, pricing, fit, or contract terms.
Listed companies — manage your entry. If you are one of the providers above and anything here is wrong, missing, or out of date — or you'd rather not be listed — let us know. Removal is processed within 24 hours; corrections within 7 business days. We do not contact listed companies first; we publish what your own public marketing claims and respond when you reach out. Email contact@aikraft.com.
Operators discussing this
These are real operators in Israel talking about this pain in their own words. They are the reason this page exists.
-
«מתוך 18 יחידות שנבדקו, רק שתיים הטמיעו את השימוש בתוכנות אלו, ושתיים נוספות נמצאות בתהליכי רכש. למרות שהתוכנות יכולות למנוע טעויות קריטיות, היחידות מדווחות על חסמי עלות ותשתיות המונעים את הטמעתן.»
"Of the 18 units audited, only two have deployed the [electronic-witness] software, and two more are in procurement. Although the software can prevent critical errors, the units report cost and infrastructure barriers blocking deployment."
"הפריה חוץ גופית: דו״ח מבקר המדינה חושף כשלים חמורים" · Doctors.co.il (Israeli physicians' professional community) — the site has carried multi-year recurrence on Israeli IVF safety: 2022 Assuta Rishon mix-up coverage, 2023 Ministry of Health committee coverage, 2024 State Comptroller coverage.
-
«אסותא ביצעה בשנה האחרונה תהליכי שיפור ניכרים, תוך הטמעת טכנולוגיות חדשות ושיפור תהליכי ניהול סיכונים ונוהלי דיווח»
"Assuta has carried out significant improvement processes this past year, including deploying new technologies and improving risk-management processes and reporting procedures." — Assuta Medical Center corporate statement, quoted alongside Dr. Hagar Mizrahi (head of the Ministry of Health medicine division).
Ynet Health — coverage of the State Comptroller findings and Ministry of Health response — operator-corporate voice in the national business press confirming the post-Sophia retrofit; cross-channel recurrence with the doctors.co.il professional-community thread.
Report a mistake — or suggest a new solution
Spot a wrong number, dead source link, missing aspect, broken translation? Or know a vendor we should list as a solution? Tell us. The Director re-checks every report and either updates the page or writes back with a reason.
Got it — thank you.
The Director will look at your report on the next research cycle. If you left an email you'll hear back when we either update the page or decide it's not actionable (with a one-paragraph reason).